Rescue, a new CRISPR platform to expand RNA editing capabilities The new system, dubbed RESCUE, allows RNA edits to be made that were not previously possible. [caption id="attachment_9342" align="aligncenter" width="1024"] The CRISPR family enzyme Cas13 at work. Cas13 (pink), is at the heart of the RESCUE platform, where it uses…..
Debiopharm and BIOASTER join forces against infectious diseases The Swiss biopharmaceutical company Debiopharm and BIOASTER, the French Technology Research Institute in infectiology have officialized a broad research agreement for the development of diagnostic and management innovation for infectious diseases. This relationship will harness BIOASTER’s scientific and technical expertise, including technology platforms,…..